Recent Updates
Recently added Catalysts
QGEN Positive Sentiment

QIAGEN Exceeds Q2 2026 Outlook as Pillars Deliver Solid Sales Growth; Reaffirms Full-Year Outlook

Wednesday, August 5, 2026 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: QIAGEN N.V. reported its Q2 2026 results, showcasing net sales of $535 million, which surpassed expectations. The company maintained profitability and achieved a 5% growth in its key growth pillars. Despite a forecasted decline, QIAGEN's performance remained stable, leading to a reaffirmation of its full-year outlook.

Market Sentiment Analysis

POSITIVE FACTORS

  • Net sales exceeded expectations despite a challenging market.
  • Adjusted diluted earnings per share showed strong performance.
  • QIAGEN reaffirmed its full-year outlook, indicating confidence in future growth.

Full Press Release Details

VENLO, Netherlands--(BUSINESS WIRE)---- $QGEN #QIAGEN--QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced results for Q2 2026, with net sales and adjusted diluted earnings per share exceeding the outlook while maintaining a high level of profitability. Net sales for Q2 2026 were unchanged at $535 million on a reported basis and at constant exchange rates (CER) compared to Q2 2025, exceeding the outlook for an approximately 2% CER decline. QIAGEN’s growth pillars together delivered 5% CER gro

Frequently Asked Questions

What were QIAGEN's net sales for Q2 2026?

QIAGEN reported net sales of $535 million for Q2 2026.

Did QIAGEN meet its sales outlook for Q2 2026?

Yes, QIAGEN exceeded its sales outlook for Q2 2026.

What growth did QIAGEN's pillars achieve?

QIAGEN's growth pillars delivered a 5% growth at constant exchange rates.

Is QIAGEN confident in its full-year outlook?

Yes, QIAGEN reaffirmed its full-year outlook, indicating strong confidence.

ShareAdd on Google
Tags: QGEN Viatris Investor Conferences Healthcare QIAGEN Q2 2026 sales growth earnings report
Last updated: Aug 5, 2026

Biotech snapshot

Lead asset
NEU-411Phase 2
Parkinson Disease →